NDC 31722-621
Dabigatran Etexilate
Dabigatran Etexilate
Dabigatran Etexilate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is Dabigatran Etexilate Mesylate.
| Product ID | 31722-621_dc10c066-1b7d-8d51-e053-2a95a90ad4aa |
| NDC | 31722-621 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dabigatran Etexilate |
| Generic Name | Dabigatran Etexilate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-05-06 |
| Marketing Category | ANDA / |
| Application Number | ANDA207961 |
| Labeler Name | Camber Pharmaceuticals, Inc. |
| Substance Name | DABIGATRAN ETEXILATE MESYLATE |
| Active Ingredient Strength | 75 mg/1 |
| Pharm Classes | Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |